LOS ANGELES, February 12, 2018
LOS ANGELES, February 12, 2018 /PRNewswire/ --
FN Media Group Presents USA News Group News Commentary
USA News Group - After sitting on the sidelines for quite some time, it appears that the big Canadian banks are willing to get into the cannabis business with BMO announcing participation.
It's positive new for the cannabis industry that is looking to expand in advance of legalization.
Companies heralding the news in the grower and producer space include Aphria (TSX: APH) (OTC: APHQF), Aurora Cannabis (TSX: ACB) (OTC: ACBFF), AmeriCann, Inc. (OTC: ACAN) and MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF).
As Marijuana legalization sweeps across the globe, Canada is arguably at the head of the pack. Since 2001, medical marijuana has been legal in the country and a bill that would legalize recreational use of the drug is currently in advanced stages of enactment.
Leaders in the producer group that are moving quickly to deal with demand include Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF), Aphria (TSX: APH) (OTCQB: APHQF), and AmeriCann, Inc (OTCQB: ACAN). These companies are already licensed legal growers of cannabis and experiencing massive demands from new markets.
Beyond the Licensed Producers (or LPs) in the grower/producer end of the business, companies are combining production with product development, sales and distribution. MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF), is one of these, with three sizeable growing operations under advancement combined with multi-brand development right through product distribution.
BMO TAKES THE LEAD
So far, financial players have been relatively slow to react to the immense opportunities that exist in the burgeoning marijuana industry. Large banks have been typically adverse to providing capital to even the medical marijuana operations.
However, these institutions may be finally turning up to the party, with (BMO) the Bank of Montreal leading an equity financing round worth $175 million for Canada's largest licensed producer, Canopy Growth Corporation.
The deal, done in partnership with investment firm GMP Capital Inc., and others like it that are likely to happen in future will give marijuana product firms access to requisite capital for future growth.
The reluctance by financial partners to avail capital to cannabis producers has impeded growth momentum in an industry that is still struggling to gain a foothold in mainstream medical and soon, the recreational industries.
Canopy's deal with BMO and GMP was largely enabled by BMO's private brokers who have long supported Canopy.
Prior to this move, producers have been forced to seek funding from individual investors, venture capital funds, and credit unions among others.
GOOD NEWS FOR ALL PLAYERS
The news has yielded solid optimism among other licensed producers, with Aurora Cannabis Executive VP Cam Battley telling the media that large banks will move in for more equity financing starting this year.
Although there has been no verbal indication to the effect, there is a possibility that Aurora might be looking to secure a deal similar to what Canopy got.
According to Canopy CEO Bruce Linton, the level of stigma that marijuana firms have traditionally faced from banks is debilitating, to the level where simply opening a bank account was nearly impossible a few years ago. He attributed this reluctance to pressure from regulators in US, where attitudes towards marijuana are much more conservative than in Canada.
The fact that Canopy does not operate in the US was therefore a key factor in the company's success with the deal with BMO.
SMALLER MYM NUTRACEUTICALS FEELING THE RIPPLE EFFECT
The effects of positive financing by the "mainstream" is expected to quickly translates to juniors like MYM Nutraceuticals - a company moving up to the field of the major legal producers in Canada.
MYM Nutraceuticals is forwarding three planned facilities; a grow operation in Laval, Quebec which just completed phase one, a joint-venture for a 1 million square foot facility in Casino, Australia and its flagship facility; a 1.5 million square foot greenhouse facility in Weedon, Quebec.
Weedon will be a massive-one of the largest grow operations on the planet. It will house the potential to produce an estimated over 150,000 kg of cannabis per year. That would bring $750 million in revenue to MYM.
In continuity its global strategy, MYM also recently signed a MOU with NEWCANNA S.A.S., a leading Colombian medical cannabis company to form a new joint-venture company.
MYM Nutraceuticals is also diversifying by advancing formulation and production to support branding and distribution of its entities Joshua Tree, MyHemp Skin Therapy, and HempMed offerings.
These subsidiaries develop and sell a variety of cannabis based natural products including custom-made cannabis products with tailored CBD chemistries along with tinctures, concentrates and oils, edibles, vape products and pet care products.
MYM does not currently have any operations in the United States and says it will not engage in that country unless significant changes to the federal laws regarding cannabis are made.
BANKS ARE PLAYING THE SAFE BET
With the pending Canadian bill largely expected to succeed in both houses, requisite regulatory frameworks aimed at quality and competition control, as well as taxation systems will come into place.
The move is seen by the current Canadian government as a great way to undercut illegal pot growers and add a new stream tax revenue.
Companies that have operations in the US market may continue to struggle to get help from lending institutions, but with no so in the Great Green North. Even without involvement of big banks, it is all guns forward for the industry.
According to Carl Merton, CEO of Aphria, the company has been able to raise $500 million without getting any banking from any major Canadian bank.
Meanwhile, Canadian cannabis companies may have set the standard for sales growth and early profits. Juniors, including MYM Nutraceuticals are seeing strong support from private equity and looking to grow quickly to keep pace.
Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF)
Through its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., Aurora Cannabis is a major LP, operating a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta. Aurora made waves when it announced the construction of its 800,000 square foot "Aurora Sky" facility second 800,000 square foot production facility at the Edmonton International Airport. Aurora's also involved in Quebec, with its third 40,000 square foot production facility set to be completed in Pointe-Claire, Quebec, on Montreal's West Island. Aurora also holds a minority stake in leading extraction technology company Radient Technologies Inc., based in Edmonton, and a minority stake in Australian company Cann Group Limited, which was the first in Australia to conduct research on and cultivate medical cannabis. Aurora also owns German wholesale importer, exporter, and EU medical cannabis distributor Pedanios.
Aphria (TSX: APH) (OTCQB: APHQF)
Aphria Inc., boasts itself as one of Canada's lowest cost producers, that produces, supplies and sells medical cannabis. Located in the greenhouse capital of Canada, Leamington, Ontario, Aphria provides pharma-grade medical cannabis, and quality patient care. Aphria was the first public LP to report positive cash flow from operations, and the first to report positive earnings in consecutive quarters.
AmeriCann, Inc. (OTCQB: ACAN)
AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi-market portfolio of over 1,000,000 square feet of sustainable cannabis production infrastructure in various stages of development. To support local businesses that seek to serve cannabis patients in their communities the company initiated the AmeriCann Preferred Partner Program. Through this program they provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner's businesses. In addition, AmeriCann's team has been instrumental in winning cannabis licenses in competitive application processes throughout the country.
For a more in-depth look into MYM you can view the in-depth report at USA News Group: http://usanewsgroup.com/2018/02/05/meet-the-biggest-sector-of-2018-and-perhaps-your-lifetime/
USA News Group
Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.
DISCLAIMER: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.
FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact Information:
FN Media Group, LLC